Your browser doesn't support javascript.
loading
Bioengineered coagulation factor VIII enables long-term correction of murine hemophilia A following liver-directed adeno-associated viral vector delivery.
Brown, Harrison C; Wright, J Fraser; Zhou, Shangzhen; Lytle, Allison M; Shields, Jordan E; Spencer, H Trent; Doering, Christopher B.
Afiliación
  • Brown HC; Graduate Program in Molecular and Systems Pharmacology, Laney Graduate School, Emory University , Atlanta, Georgia, USA.
  • Wright JF; Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia , Philadelphia, Pennsylvania, USA ; Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania, USA.
  • Zhou S; Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia , Philadelphia, Pennsylvania, USA.
  • Lytle AM; Graduate Program in Molecular and Systems Pharmacology, Laney Graduate School, Emory University , Atlanta, Georgia, USA.
  • Shields JE; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Emory University School of Medicine , Atlanta, Georgia, USA.
  • Spencer HT; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Emory University School of Medicine , Atlanta, Georgia, USA.
  • Doering CB; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Emory University School of Medicine , Atlanta, Georgia, USA.
Mol Ther Methods Clin Dev ; 1: 14036, 2014.
Article en En | MEDLINE | ID: mdl-26015976

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2014 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2014 Tipo del documento: Article